GABA transaminase deficiency
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
GABA transaminase deficiency. This is caused by mutations in the GABA transaminase (GABAT) gene. Fully referenced neurology checklist.
Genetics
- This is caused by mutations in the GABA transaminase (GABAT) gene
- It results in GABAT deficiency and high levels of GABA in the serum and CSF
- The transmission is autosomal recessive
- It causes neonatal or early infantile epilepsy
Clinical features
Locked: subscribe to see this section.
Electroencephalogram (EEG): features
Locked: subscribe to see this section.
Treatment
Locked: subscribe to see this section.
Acronym
Locked: subscribe to see this section.
References
- Koenig MK, Hodgeman R, Riviello JJ, et al. Phenotype of GABA-transaminase deficiency. Neurology 2017; 88:1919-1924.
- Louro P, Ramos L, Robalo C, et al. Phenotyping GABA transaminase deficiency: a case description and literature review. J Inherit Metab Dis 2016; 39:743-747.
- Medina-Kauwe LK, Nyhan WL, Gibson KM, Tobin AJ. Identification of a familial mutation associated with GABA-transaminase deficiency disease. Neurobiol Dis 1998; 5:89-96.
- Morales-Briceño H, Chang FCF, Wong C, et al. Paroxysmal dyskinesias with drowsiness and thalamic lesions in GABA transaminase deficiency. Neurology 2019; 92:94-97.
Related checklists
- BRAT1 epileptic encephalopathy
- CDKL5 epileptic encephalopathy
- DNM1 epileptic encephalopathy
- Early myoclonic encephalopathy (EME)
- FOXG1 encephalopathy
- GLUT1 deficiency disease (G1D)
- GMAT deficiency syndrome
- GRIN2B epileptic encephalopathy
- Harel-Yoon syndrome (HYS)
- Hemiconvulsion–hemiplegia (HH) syndrome
- KCNT1 epileptic encephalopathy
- PACS2 related epileptic encephalopathy
- PCDH19 related epileptic encephalopathy
- STX1B epileptic encephalopathy
- STXBP1 epileptic encephalopathy
- SYNGAP1 epileptic encephalopathy